Dutasteride vs. Finasteride Hair Evidence: Key Differences
Explained: mechanism, results, side effects, and questions to ask your dermatologist.

Save articles to read later and create your own reading list.

Explained: mechanism, results, side effects, and questions to ask your dermatologist.
- Both drugs inhibit 5-alpha reductase, the enzyme converting testosterone to DHT.
- Finasteride blocks mainly type II; dutasteride blocks type I and type II.
- Head-to-head trial data favors dutasteride for hair-count gains.
- Finasteride is FDA-approved for hair loss; dutasteride is off-label in the US.
- Side effect profiles overlap; dutasteride's long half-life prolongs effects.
- Neither drug is safe for women who are or may become pregnant.
Frequently asked questions
Trial data, including the Olsen 2006 head-to-head study, shows dutasteride produces greater hair-count gains because it suppresses DHT more completely. However, finasteride has longer-term safety data and FDA approval for hair loss, so 'better' depends on your risk tolerance and your doctor's assessment.
Most men need 3-6 months before shedding stabilizes and 6-12 months for visible thickening. Photos every 4-8 weeks are the best way to judge response, since day-to-day mirror checks are unreliable.
Yes, switching is common when finasteride response is incomplete after 12 months. Your dermatologist will typically assess tolerance, side effects, and goals before changing drugs, since dutasteride's effects persist longer after stopping.
Most sexual side effects in trials resolved after discontinuation, and dutasteride's longer half-life means resolution can take weeks to months. Reports of persistent symptoms exist but are uncommon and debated; discuss your personal risk honestly with your doctor.
These drugs are generally avoided in women who are or may become pregnant because of risks to male fetal development. Postmenopausal women with androgenetic alopecia are sometimes prescribed them off-label under specialist supervision.
Hair gained or retained during treatment is typically lost within 6-12 months of stopping, as DHT levels recover. These drugs manage rather than cure pattern hair loss, so stopping should be a planned decision with your clinician.
Yes. Donations made directly to GoWithFund Inc. (a registered 501(c)(3) public charity in Idaho, EIN: 33-1243835) or to its verified fiscally sponsored projects are tax-deductible to the fullest extent permitted under IRC Section 170. Donors automatically receive official IRS substantiation receipts via email.
Direct 501(c)(3) incorporation requires forming a nonprofit corporation, drafting bylaws, recruiting an independent board of directors, paying IRS Form 1023 filing fees ($275 or $600), and waiting 3 to 12 months for IRS determination. Comprehensive fiscal sponsorship allows mission-driven projects to launch immediately under an established charity's legal umbrella with zero corporate overhead.
Organizations with gross annual receipts normally <= $50,000 file the electronic Form 990-N (e-Postcard). Organizations with gross receipts < $200,000 and total assets < $500,000 may file Form 990-EZ. Organizations exceeding those thresholds must file full Form 990 annually by the 15th day of the 5th month after their fiscal year closes.
Payments processed through third-party payment settlement entities (like Stripe) may generate a Form 1099-K if gross transaction volumes exceed prevailing IRS or state reporting thresholds. However, bona fide personal charitable gifts and tax-exempt contributions are generally not considered gross taxable income.
Under IRC Section 170(f)(8), donors must obtain a contemporaneous written acknowledgment (CWA) from the recipient charity before filing their federal tax return. GoWithFund automatically issues receipts containing the organization's EIN, donation amount, date, and a statement confirming no goods or services were provided in return.
A for-profit entity cannot be fiscally sponsored for general corporate operations. However, specific charitable, educational, or scientific programs operated by social enterprises can receive grant funding under Comprehensive Model A or Pre-Approved Grant Relationship Model C fiscal sponsorships provided all funds are restricted strictly to 501(c)(3) exempt activities.
GoWithFund charges a 0% platform fee on all charitable campaigns and donations. 100% of the net contribution directly supports the initiative, with only standard third-party Stripe payment processing fees (2.9% + $0.30 per transaction) applying, which donors can voluntarily choose to cover at checkout.
Verified campaign organizers receive automated direct bank payouts via Stripe Connect within 1 to 2 business days after statutory verification, eliminating weeks of manual check clearing or intermediary administrative delays.

GoWithFund Editorial Team
Staff Contributor
Published on behalf of GoWithFund Inc., a registered U.S. 501(c)(3) tax-exempt public charity in Idaho (EIN: 33-1243835 | Idaho SOS #5902503). Articles are reviewed for statutory compliance under IRS Internal Revenue Code Section 170.
Related Topics
Put these Hair Grow solutions into practice
Launch your initiative, access verified tools, and streamline your operations with 0% platform fee infrastructure.
Related Articles

Ozempic Hair Loss Recovery: Timeline & What Helps
Explained: why shedding happens on GLP-1 drugs, realistic timelines, nutrition fixes, and how to track regrowth.

GoWithFund Editorial Team
Staff Contributor

Hair Growth for Teens: SAFE
Explained: what's normal in puberty, nutrition, gentle routines, and when to see a doctor. Practical, parent-friendly guidance.

GoWithFund Editorial Team
Staff Contributor

Hair Growth Gummies: What Works
Reviewed: key ingredients, evidence, dosage, and red flags—plus how to track results with the GoWithFund Hair Grow app.

GoWithFund Editorial Team
Staff Contributor
